Evox therapeutics is a science driven healthcare company focused on developing novel engineered exosome-based therapeutics. We aim to deliver growth through addressing the high unmet needs in rare diseases.
Sharing our belief in the therapeutic potential of exosomes, Evox is supported by an experienced blue-chip investor syndicate which includes:
